This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Steven A. Lemmel: Innovator in Biotechnology
Introduction
Steven A. Lemmel is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of biotechnology, particularly in the development of constructs that express beta-casein.
Latest Patents
Lemmel holds a patent for his invention titled “β-casein expressing constructs.” This patent relates to constructs that exhibit significant stability when introduced into host cells. The constructs, designated as pRAB-84-69 and pRSB-14, comprise an isolated DNA sequence that includes a nucleotide sequence encoding a protein linked to a promoter, as well as sequences encoding kinase subunits, a peptidase, and a bacterial resistance marker. These constructs can be utilized in the production of recombinant human beta-casein.
Career Highlights
Lemmel is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work focuses on innovative solutions that enhance the stability and efficacy of biotechnological products.
Collaborations
Throughout his career, Lemmel has collaborated with talented professionals, including Pradip Mukerji and Amanda Eun-Yeong Leonard. These collaborations have contributed to the advancement of his research and innovations.
Conclusion
Steven A. Lemmel's contributions to biotechnology, particularly through his patent on beta-casein expressing constructs, highlight his role as an innovator in the field. His work continues to influence advancements in recombinant protein production.